Education
About Us
Working with TipRanks
Follow Us
Nurexone Biologic Inc. (TSE:NRX)
:NRX
NRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.52 - C$0.83
Previous CloseN/A
VolumeN/A
Average Volume (3M)34.91K
Market Cap
C$40.96M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)31.00K
Price to Earnings (P/E)―
Beta-0.19
Next Earnings
Sep 02, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding59,357,914
10 Day Avg. Volume24,195
30 Day Avg. Volume34,912
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.61Price Target Upside278.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
NurExone Biologic News
PremiumCompany Announcements
NurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026
PremiumCompany Announcements
NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements
PremiumCompany Announcements
NurExone Biologic Expands European Engagement with Key Investor Events
PremiumCompany Announcements
NurExone Unveils Breakthrough in Facial Nerve Regeneration at ISEV 2025
PremiumCompany Announcements
NurExone Expands U.S. Operations with New Leadership and Ontario ContinuanceOptions Prices
Currently, No data available
---
Ownership Overview
0.37% Insiders
―
Mutual Funds
― Other Institutional Investors
99.63% Public Companies and
Individual Investors
NRX FAQ
What was Nurexone Biologic Inc.’s price range in the past 12 months?
Nurexone Biologic Inc. lowest stock price was C$0.52 and its highest was C$0.83 in the past 12 months.
What is Nurexone Biologic Inc.’s market cap?
Nurexone Biologic Inc.’s market cap is C$40.96M.
When is Nurexone Biologic Inc.’s upcoming earnings report date?
Nurexone Biologic Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 64 days.
How were Nurexone Biologic Inc.’s earnings last quarter?
Nurexone Biologic Inc. released its earnings results on May 27, 2025. The company reported -C$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.02.
Is Nurexone Biologic Inc. overvalued?
According to Wall Street analysts Nurexone Biologic Inc.’s price is currently Undervalued.
Does Nurexone Biologic Inc. pay dividends?
Nurexone Biologic Inc. does not currently pay dividends.
What is Nurexone Biologic Inc.’s EPS estimate?
Nurexone Biologic Inc.’s EPS estimate is -0.03.
How many shares outstanding does Nurexone Biologic Inc. have?
Nurexone Biologic Inc. has 59,357,914 shares outstanding.
What happened to Nurexone Biologic Inc.’s price movement after its last earnings report?
Nurexone Biologic Inc. reported an EPS of -C$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Nurexone Biologic Inc.?
Currently, no hedge funds are holding shares in TSE:NRX
NurExone Biologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$2.61 (278.26% Upside)
C$2.61 (278.26% Upside)
Insider Transactions
Bought Shares
Worth C$2.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.47%
12-Months-Change
Fundamentals
Return on Equity
-237.60%
Trailing 12-Months
Asset Growth
-45.05%
Trailing 12-Months
Company Description
Nurexone Biologic Inc.
EnerSpar Corp is a Canada based company. Its business is the acquisition, exploration, and development of resource property especially in the field of industrial minerals. Its project includes the Johan Beetz Feldspar property.
Technical Analysis
Rapid Dose Therapeutics Corp
―
Helix BioPharma
―
Microbix Biosystms
―
Defence Therapeutics
―
Thiogenesis Therapeutics Corp
―